UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report:
(Date of earliest event reported)
February 15, 2019
____________________________
GROWLIFE, INC.
(Exact name of registrant as specified in charter)
Delaware
(State or other Jurisdiction of Incorporation or
Organization)
000-50385
(Commission
File Number)
|
|
90-0821083
(IRS
Employer Identification No.)
|
|
5400 Carillon Point
Kirkland, WA 98033
(Address
of Principal Executive Offices and zip code)
|
|
(866) 781-5559
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
1.02 - Termination of Material Definitive
Agreement
Termination of all Agreements with CANX and Cancellation of CANX
Warrants
On
February 15, 2019, GrowLife, Inc. (the “Company”),
entered into a Termination of Existing Agreements and Release (the
“Agreement”) with CANX USA, LLC, a Nevada limited
liability company (“CANX”). Pursuant to the Agreement,
the Parties agreed to terminate,
release and discharge all existing and further rights and
obligations between the Parties under, arising out of, or in any
way related to that certain Waiver and Modification Agreement and Amended and
Restated Joint Venture Agreement made as of July 10, 2014, and any
ancillary agreements or instruments thereto, including, but not
limited to, the Warrants issued to CANX entitling CANX to purchase
540,000,000 shares of the Company’s common stock at an
exercise price of $0.033 (collectively, the “CANX Agreements
and Warrants”).
In exchange for the Agreement and cancellation of the CANX
Agreements and Warrants, the Company agreed to issue $1,000,000 of
restricted common stock priced at the February 7, 2019 closing
price of $0.008, or 125,000,000 restricted common stock shares (the
“Shares”).
The foregoing description of the Agreement is not complete and is
subject to and qualified in its entirety by reference to the
Agreement as set forth within Exhibit 10.1 attached hereto and
incorporated herein by this reference. All defined terms not
otherwise defined herein shall have the meaning as set forth in the
Agreement.
Item 3.02 Unregistered Sales of Equity
Securities
See the disclosures made in Item 1.02, which are incorporated
herein by reference. The Company’s securities were issued to
an accredited investor in a transaction exempt from registration
pursuant to Section 4(2) of the Securities Act of 1933. The
transaction did not involve a public offering, the sale of the
securities was made without general solicitation or advertising,
there was no underwriter, and no underwriting commissions were
paid.
Item 7.01 Regulation FD Disclosure.
Attached hereto as Exhibit 99.1 is a press release the Company
issued on February 19, 2019, announcing entry into the
Agreement. The
information provided in response to Item 1.02 of this report is
incorporated by reference into this Item 7.01.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
Termination of Existing Agreements and Release Agreement
accepted February 15, 2019, entered into by and between
GrowLife, Inc. and CANX USA, LLC
|
|
|
Press
Release issued by GrowLife, Inc., dated February 20, 2019,
regarding the Agreement with CANX
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
GROWLIFE, INC.
|
|
|
|
|
Date: February
20, 2019
|
By:
|
/s/
Marco Hegyi
|
|
|
Marco
Hegyi
|
|
|
Chief
Executive Officer
|
February
8, 2019
By Email Only
CANX
USA, LLC
410
South Rampart Blvd., Suite 350
Las
Vegas, NV 89145
Re:
OFFER TO TERMINATE
EXISTING AGREEMENTS AND RELEASE
Dear
CANX USA LLC,
Reference is made to that certain Waiver and
Modification Agreement and Amended and Restated Joint Venture
Agreement made as of July 10, 2014, and any ancillary agreements or
instruments thereto (collectively, the “Existing
Agreements”), by and among GrowLife, Inc.
(“GrowLife” or “PHOT”) and CANX USA, LLC,
(“CANX” and together with GrowLife, the
“Parties”). In connection with the Existing Agreements,
CANX became the holder of the warrants, which entitled you to
purchase 540,000,000 shares of
GrowLife Common Stock (the
“Warrants”).
The purpose of this letter is to present the
following the following “Offer” which shall expire if
not accepted with notice delivered to Mr. Hegyi prior to
11:59
PM PST Sunday, February 10, 2019.
In
consideration for a one time lump sum issuance of $1,000,000 in
PHOT common stock priced at the February 7, 2019 closing price of
$0.008, or 125,000,000 restricted common stock shares (the
“Shares”) issued directly to CANX, GrowLife and CANX
agree to terminate any existing or further rights and obligations
between the Parties under, arising out of, or in any way related to
each of the Existing Agreements or the Warrants, the Warrants shall
be cancelled and returned to treasury, and GrowLife shall terminate
any and all relationship with Organic Growth International, LLC.
The Parties further agree to release fully and finally, any and all
claims, disputes, actions, or rights, known or unknown, which may
now exist or heretofore have existed, between the Parties relating
to the Existing Agreement or the Warrants or arising therefrom.
Upon acceptance and countersigned execution copies of this
Agreement, all rights and obligations under the Existing Agreements
and the Warrants will be terminated and of no further force or
effect, and each of the Parties shall be released from their
respective obligations thereunder.
GrowLife
is a fully reporting publically traded company. As such, the Shares
shall be eligible for deposit and public resale with the broker of
your choice pursuant to Rule 144 six (6) months after the date this
Offer is accepted and the Shares are issued to CANX. As additional
consideration, GrowLife will pay a maximum fee of $300 for CANX to
acquire a legal opinion for the removal of the Rule 144
legend.
In addition to the consideration and mutual
covenants referenced above, CANX and GrowLife, each of them,
hereby represents and warrants to, and agrees with, each of the
other that it has carefully read and reviewed this Agreement in its
entirety and understands it fully, has had an opportunity to review
the terms of this Agreement with independent legal counsel of its
choice prior to executing this Agreement, and has executed this
Agreement of its own free will. CANX and GrowLife each acknowledge
that the person executing this Agreement has the authority to
execute this Agreement on behalf of GrowLife or CANX, as
applicable, on whose behalf said person is purporting to execute it
and each corporate or limited liability company Party hereto
represents and warrants that the execution and delivery of this
Agreement has been duly authorized and approved.
CANX
and GrowLife further agree that this Agreement is intended to be
final and binding between and among, and to inure to the benefit of
the Parties, including their heirs, executors, personal
representatives, attorneys, successors and assigns, and is further
intended to be effective as a full and final accord and
satisfaction between and among the Parties regardless of any claims
of fraud, misrepresentation, concealment of fact, mistake of fact
or law, breach of fiduciary duty or any other claims or
circumstances that have occurred as of the date hereof. Each Party
relies on the finality of this Agreement as a material factor
inducing that Party’s execution of this
Agreement.
The
term of the Offer made by GrowLife in this letter shall expire at
11:59
PM Pacific Standard Time on Sunday, February 10, 2019,
unless sooner accepted by CANX by signing below and returning an
executed copy of this letter agreement to GrowLife prior to the
time of expiration.
Very
truly yours,
|
GROWLIFE,
INC.
|
|
|
|
|
|
|
By:
|
/s/
Marco
Hegyi
|
|
|
Name:
|
Marco
Hegyi
|
|
|
Title:
|
President and
CEO
|
|
ACCEPTED AND AGREED TO:
|
CANX USA,
LLC:
|
|
|
|
|
|
|
By:
|
/s/
Tony
Cox
|
|
|
Name:
|
Tony
Cox, Authorized Signatory
|
|
GrowLife, Inc. Announces Retirement of Over One-Half Billion
Shares
KIRKLAND,
Wash., February 20, 2019 --
GrowLife, Inc. (OTCQB:PHOT),
one of the nation's most
recognized indoor cultivation product and service providers, today
announced that GrowLife and CANX USA, LLC, (“CANX”)
have completed an agreement to terminate all past agreements
between the parties including that which entitled CANX to receive
up to 540,000,000 shares of GrowLife Common Stock priced at $0.033
related to the exercise of Warrants. Effective immediately,
all existing or further rights and obligations between the
parties under, arising out of, or in any way related to each of the
existing agreements and the Warrants have been terminated in
exchange for a one-time lump sum issuance of $1,000,000 in PHOT
common stock priced at the February 7, 2019 closing price of
$0.008, or 125,000,000 restricted common stock shares issued
directly to CANX. As a result there are no further rights,
obligations, or relationship between the two
companies.
“After years of extensive and cooperative negotiations I am
pleased to report that GrowLife has taken a significant step
towards strenthening our balance sheet with the cancellation of
warrants to purchase of up to 540 million common shares,”
said GrowLife CEO Marco Hegyi. “CANX provided necessary
support in 2013 and 2014 that entitled CANX to 540,000,000 shares
at $0.033, which was was consided to be a supressive
‘overhang’ to PHOT’s share price by many
investors. By issuing 125,000,000 restricted shares priced at
$0.008, we have retired the enire CANX overhang. I see this as a
win-win to both PHOT shareholders and CANX
investors.”
For more information about GrowLife, please visit the
company's
website.
Products can be purchased at
ShopGrowLife.com. Additional commentary on
the company and the industry as a whole can be found on the
CEO's
blog.
About GrowLife, Inc.
GrowLife, Inc. (PHOT) aims to become the
nation’s largest cultivation service provider for cultivating
organics, herbs and greens and plant-based medicines. Our mission
is to help make our customers successful. Through a network of
local representatives covering the United States and Canada,
regional centers and its e-Commerce team, GrowLife provides
essential goods and services including media, industry-leading
hydroponics and soil, plant nutrients, and thousands more products
to specialty grow operations. GrowLife is headquartered in
Kirkland, Washington and was founded in 2012.
Public Relations Contact:
CMW
Media
Cassandra
Dowell, 858-264-6600
cassandra@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
info@growlifinc.com
206-483-0059
FORWARD LOOKING STATEMENT:
This release contains statements that constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. These statements appear in a number of places
in this release and include all statements that are not statements
of historical fact regarding the intent, belief or current
expectations of GrowLife, Inc., its directors or its officers with
respect to, among other things: (i) financing plans; (ii) trends
affecting its financial condition or results of operations; (iii)
growth strategy and operating strategy. The words may, would, will,
expect, estimate, can, believe, potential and similar expressions
and variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond GrowLife,
Inc.’s ability to control, and actual results may differ
materially from those projected in the forward-looking statements
as a result of various factors.